Skip to main content
Equibles

Bank of New York Mellon Corp

Bank

Position in MGNX — Macrogenics Inc

CIK 1390777 NEW YORK, NY
Back to MGNX Full portfolio

Position in MGNX

as of Jun 30, 2026 · filed Aug 6, 2026
Position Value
$626,271
+$427,153 QoQ
Shares Held
135,557
-13.5% QoQ
Ownership
0.213%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#38
of 122 holders
Holding Since
Mar 2020
22 quarters on record
Voting authority Sole 96% Shared 0% None 4%

Common Shares in MGNX Over Time

Shares Held

Position Value (USD)

Position in Biotechnology

Healthcare · as of Jun 30, 2026

Bank of New York Mellon Corp holds $4,864,365,655 across 311 Biotechnology names. MGNX ranks #225 (0.0% of the industry book) .

# Ticker Company Shares Value (USD) Open
1 VRTX
Vertex Pharmaceuticals Inc / Ma
 1,672,623 $830,842,010
2 REGN
Regeneron Pharmaceuticals, Inc.
 758,492 $472,950,091
3 JAZZ
Jazz Pharmaceuticals plc
 1,578,013 $380,253,782
4 ALNY
Alnylam Pharmaceuticals, Inc.
 492,071 $148,128,128
5 INSM
INSMED Inc
 1,312,756 $139,966,036
6 MRNA
Moderna, Inc.
 1,701,675 $119,168,293
7 RVMD
Revolution Medicines, Inc.
 601,056 $112,565,759
8 INCY
Incyte Corp
 972,825 $110,279,435

All Filings in MGNX

Export CSV
22 filing rows on record
Report Date Value (USD) Shares
2026-06-30 $626,271 135,557
2025-03-31 $199,118 156,787
2024-12-31 $539,895 166,122
2024-09-30 $719,063 218,561
2024-06-30 $1,113,260 261,944
2024-03-31 $3,675,684 249,707
2023-12-31 $2,549,991 265,072
2023-09-30 $926,624 198,847
2023-06-30 $1,059,850 198,103
2023-03-31 $1,419,177 197,933
2022-12-31 $1,389,839 207,130
2022-09-30 $729,984 210,979
2022-06-30 $563,109 190,885
2022-03-31 $1,748,624 198,482
2021-12-31 $3,171,061 197,574
2021-09-30 $4,127,398 197,106
2021-06-30 $4,702,862 175,088
2021-03-31 $9,123,463 286,451
2020-12-31 $5,157,969 225,633
2020-09-30 $5,396,099 214,216
2020-06-30 $5,866,158 210,106
2020-03-31 $1,212,298 208,299